Loading data for BIB — first visit, this takes a few seconds.
ProShares Ultra Nasdaq Bi... (BIB)
NasdaqGM: BIB
· Echtzeitkurs · USD
118.91
-7.30 (-5.78%)
Zum Schluss: Aug 20, 2026, 8:00 PM
118.91
+0.10%
Nachbörslich: 4:10 PM
ProShares Ultra Nasdaq Biotechnology (BIB) ETF-Kurs, Bestände & Analyse
-5.78% (1D)
Keine Daten verfügbar
| Geld | k.A. |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 78.22 Mio |
| NAV | 111.92 |
| Beta | 1.13 |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | 33.67 |
| Ausstehende Anteile | k.A. |
| Auflagedatum | Apr 6, 2010 |
| Brief | k.A. |
| Volumen | 24,920 |
| Ø Vol. (20D) | 11,000 |
| Eröffnung | 122.32 |
| Vortagesschluss | 126.21 |
| Tagesspanne | 118.79 - 122.73 |
| 52-Wk Range | 54.56 - 126.40 |
| Positionen | k.A. |
| Kostenquote | 0.95% |
Über BIB
The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
Anlageklasse Equity
Tickersymbol BIB
Auflagedatum Apr 6, 2010
Anbieter Proshares
Website Fonds-Homepage
Börse NasdaqGM
Dividenden Dividendenrendite 0.42%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Mar 25, 2026 | $0.0070 | k.A. |
| Dec 24, 2025 | $0.1350 | k.A. |
| Sep 24, 2025 | $0.1810 | k.A. |
| Jun 25, 2025 | $0.1710 | k.A. |
| Mar 26, 2025 | $0.1310 | k.A. |
